Honglian Ma

HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer

Yirui Zhai, Honglian Ma, Zhouguang Hui et al. · Radiotherapy and Oncology · 2018 · 37 citations · Full text

Radiation Medicine, Phase Ii Trial, Radiation Therapy +9

A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma

Jie Peng, Dan Zou, Xudong Zhang et al. · Journal of Translational Medicine · 2024 · 24 citations · Full text

Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy

Huarong Tang, Honglian Ma, Fang Peng et al. · Molecular and Clinical Oncology · 2016 · 17 citations · Full text

Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer

Yujin Xu, Jianqiang Li, Jin Wang et al. · Oncology Letters · 2017 · 12 citations · Full text

Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non‐small cell lung cancer: Updated follow‐up results from two phase II trials

Honglian Ma, Zhouguang Hui, Fang Peng et al. · Thoracic Cancer · 2020 · 12 citations · Full text